CD4 and melanoma: However, in our previous study using this same line of CD4+ T lymphocyte-specific SHP2 knockout (SHP2CD4−/−) mice, we found that SHP2 deletion promoted progression and metastasis of melanoma via IL-6-myeloid derived suppressor cells cascade [19].